Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638521 · ClinicalTrials.gov registry record
Immune-cell Membrane Trafficking
A clinical trial of Severe Trauma, sponsored by University of Washington.
- Completed
- Registry status
- 213
- Enrollment target
- 1
- Study location
NCT00638521: Completed study of Severe Trauma, sponsored by University of Washington.
NCT00638521 is a study of Severe Trauma that has completed, run by University of Washington. The registered enrollment target is 213 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00638521, a study of Severe Trauma, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
- 1
- Study location
Study Summary
Organ failure following trauma is a leading cause of morbidity and mortality. It appears that the development of organ failure is a direct result of an altered immune response. This altered response results in the production of circulating factors in the blood that causes direct injury to the injured patients' organs. The mechanism in which this altered immune response occurs is unknown. Based on work we have performed in our laboratory, we believe that this response is initiated on the cell membrane of particular immune cells known as macrophages. Although the cell membrane may appear uniform, it is not. The membrane is composed of specific segments that allow proteins to associate with each other forming receptors that are required for immune cell activation. These specific membrane components are composed of various lipids and cholesterol, and have been termed lipid rafts. Based on our laboratory work it appears that these lipid rafts can be altered following injury. In particular both the lipid and protein content within these raft segments may be altered allowing immune cells to become active leading to the production of factors that directly injure normal cells and organs. Thus, we plan to examine if these laboratory findings can be seen in patients suffering from trauma who develop clinical organ failure at Harborview Medical Center. If this is accomplished, this data will lead to the development of both prognostic and therapeutic interventions for the optimal care of injured patient
Conditions Studied
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
What the finished NCT00638521 record still lists
NCT00638521 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Severe Trauma appearing as the primary indexed condition, and to 0 interventions.
NCT00638521 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00638521 about?
NCT00638521 is a clinical study titled "Immune-cell Membrane Trafficking". Organ failure following trauma is a leading cause of morbidity and mortality. It appears that the development of organ failure is a direct result of an altered immune response. This altered response results in the production of circulating factors in the blood that causes direct injury to the injure...
What is the current status of trial NCT00638521?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2008-06. Estimated completion is 2013-06.
What conditions does trial NCT00638521 study?
This clinical trial studies the following conditions: Severe Trauma.
Who is sponsoring clinical trial NCT00638521?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00638521 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia